Bing Chen
- Virology top 0.2%
- HIV Research and Treatment 36
- Infectious Diseases top 0.05%
- SARS-CoV-2 and COVID-19 Research 22
- Tuberculosis Research and Epidemiology 21
- HIV/AIDS drug development and treatment 13
- Immunology top 0.5%
- Immune Cell Function and Interaction 14
- Molecular Medicine top 1%
- Epidemiology top 0.5%
- Mycobacterium research and diagnosis 19
-
- Monoclonal and Polyclonal Antibodies Research 12
-
- Remote Sensing in Agriculture 9
Bing Chen
121 papers receiving 11.0k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Virology 2.2k
- Infectious Diseases 7.1k
- Immunology 2.5k
- Molecular Medicine 406
- Epidemiology 2.8k
Countries citing papers authored by Bing Chen
This map shows the geographic impact of Bing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Chen more than expected).
Fields of papers citing papers by Bing Chen
This network shows the impact of papers produced by Bing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Chen. The network helps show where Bing Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 55 | |
| 6 | 2022 | 14 | |
| 7 | 2022 | 34 | |
| 8 | 2022 | 17 | |
| 9 | 2022 | 67 | |
| 10 | Structural impact on SARS-CoV-2 spike protein by D614G substitutionbreakdown → | 2021 | 270 |
| 11 | Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variantbreakdown → | 2021 | 190 |
| 12 | 2021 | 154 | |
| 13 | Distinct conformational states of SARS-CoV-2 spike proteinbreakdown → | 2020 | 765 |
| 14 | 2020 | 94 | |
| 15 | 2019 | 1 | |
| 16 | 2019 | 14 | |
| 17 | 2019 | 2 | |
| 18 | 2017 | 6 | |
| 19 | 2013 | 81 | |
| 20 | 2007 | 256 |
About Bing Chen
Bing Chen is a scholar working on Virology, Infectious Diseases and Immunology, having authored 128 papers that have together received 11.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (36 papers), SARS-CoV-2 and COVID-19 Research (22 papers), Tuberculosis Research and Epidemiology (21 papers), Mycobacterium research and diagnosis (19 papers), Immune Cell Function and Interaction (14 papers), HIV/AIDS drug development and treatment (13 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Remote Sensing in Agriculture (9 papers). The work is most often cited by research in Virology (2.2k citations), Infectious Diseases (7.1k citations) and Immunology (2.5k citations). Bing Chen has collaborated with scholars based in United States, China and Poland. Frequent co-authors include Michael Farzan, Hyeryun Choe, Cody B. Jackson, William R. Jacobs, Sophia Rits‐Volloch, Hanqin Peng, Yongfei Cai, Tianshu Xiao, Jun Zhang and Stephen C. Harrison. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Virology, Science, Nature and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.